Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.0K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol for the SACLA trial: Efficacy and safety of subretinal monteplase for submacular hemorrhage in a phase II single-arm multicenter decentralized clinical trial.

PloS one·2026
Same author

Impact of Preoperative Ocular Hypotony on Refractive Predictability After Phacovitrectomy for Rhegmatogenous Retinal Detachment.

Life (Basel, Switzerland)·2026
Same author

Fundus Autofluorescence as a Sensitive Biomarker of Disease Progression in Bietti Crystalline Dystrophy.

Ophthalmology science·2026
Same author

Environmental and Climatic Drivers of Microsporidial Keratoconjunctivitis in Athletes: Molecular Evidence from Outbreaks in Japan.

Microorganisms·2026
Same author

Risk of Glaucoma and Undergoing Glaucoma Surgery in Myopic and Highly Myopic Eyes: A Nationwide Population-Based Cohort Study.

Ophthalmology·2026
Same author

Flexible Loading Phase Treat-and-Extend Regimen with Faricimab for Neovascular Age-Related Macular Degeneration: A Real-World Study.

Biomedicines·2025

Related Experiment Video

Updated: Jun 28, 2025

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

2.0K

Phototoxicity avoidance is a potential therapeutic approach for retinal dystrophy caused by EYS dysfunction.

Yuki Otsuka1,2,3, Keiko Imamura1,2,4, Akio Oishi5

  • 1iPSC-based Drug discovery and Development Team, RIKEN BioResource Research Center, Kyoto, Japan.

JCI Insight
|April 22, 2024
PubMed
Summary

Mutations in the eyes shut homolog (EYS) gene cause inherited retinal dystrophies (IRDs). EYS gene mutations disrupt photoreceptor cells, making them vulnerable to light, suggesting phototoxicity avoidance as a therapy for EYS-RD.

Keywords:
OphthalmologyRetinopathyStem cells

More Related Videos

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases
07:46

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

897
Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
07:43

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

1.9K

Related Experiment Videos

Last Updated: Jun 28, 2025

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

2.0K
Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases
07:46

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

897
Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
07:43

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

1.9K

Area of Science:

  • Ophthalmology
  • Genetics
  • Cell Biology

Background:

  • Inherited retinal dystrophies (IRDs) cause progressive vision loss.
  • Mutations in the eyes shut homolog (EYS) gene are a frequent cause of IRDs.
  • The precise mechanism of photoreceptor degeneration in EYS-associated retinal dystrophy (EYS-RD) remains unclear.

Purpose of the Study:

  • To investigate the mechanism of photoreceptor cell degeneration in EYS-RD.
  • To utilize patient-derived induced pluripotent stem cells (iPSCs) to create retinal organoids for studying EYS-RD.
  • To explore the role of EYS and phototoxicity in the disease pathology.

Main Methods:

  • Generated retinal organoids from iPSCs of patients with EYS-RD.
  • Examined the localization of EYS and GRK7 in photoreceptor cells of the organoids.
  • Assessed the vulnerability of photoreceptor cells to light stimuli, particularly blue light.
  • Investigated the effect of EYS gene delivery on photoreceptor function.

Main Results:

  • Photoreceptor cells in EYS-RD organoids showed mislocalization of EYS and GRK7 from the outer segment.
  • These photoreceptor cells exhibited increased vulnerability to light, especially blue light.
  • Mislocalization of GRK7 was also observed in eys-knockout zebrafish models.
  • Restoring EYS in RD organoid photoreceptor cells corrected GRK7 mislocalization.

Conclusions:

  • EYS mutations lead to photoreceptor outer segment dysfunction and light sensitivity in EYS-RD.
  • Mislocalization of GRK7 contributes to phototoxicity in EYS-RD.
  • Targeting phototoxicity represents a potential therapeutic strategy for EYS-RD.